Table 2 Adverse events of interest
Adverse Event | ddAC cycle number | Grade I N (%) | Grade II N (%) |
|---|---|---|---|
Bone pain | |||
1 | 0 (0%) | 1 (2.5%) | |
2 | 12 (30%) | 2 (5%) | |
3 | 10 (25%) | 1 (2.5%) | |
4 | 7 (17.5%) | 2 (5%) | |
Myalgia | |||
1 | 0 (0%) | 0 (0%) | |
2 | 3 (7.5%) | 1 (2.5%) | |
3 | 2 (5%) | 0 (0%) | |
4 | 3 (7.5%) | 0 (0%) | |
Injection site reaction | |||
1 | 0 (0%) | 0 (0%) | |
2 | 1 (2.5%) | 0 (0%) | |
3 | 0 (0%) | 0 (0%) | |
4 | 0 (0%) | 0 (0%) |